Chapter 11
Immunological Memory and Secondary Immune Response
Relies on:
antibodies
long-lived memory T/B cells
each activated T/B cell undergoes asymmetric division to give one effector cell and one memory cell
secondary responses are faster, better
Why secondary responses are faster and better
memory cells outnumber pathogen specific naive lymphocytes
antibodies formed during primary immune response prevent reinfection for several months after disease
memory cells activated quicker
pathogen-specific memory cells more abundant and make better antibodies than naive B cells
somatic hypermutation, affinity maturation
isotype switching already happened
memory cells can migrate to non-lymphatic tissue and respond sooner
can be activated at SOI
activation of naive B lymphocytes is inhibited
naive B cell activation suppressed
memory antibodies turn off naive B cells
Vaccines
2 ingredients
target antigen(s)
provides signal 1 for T cell activation
many vaccines are combination vaccines that contain multiple antigens
adjuvant
chemical that stimulates inflammation
provides signal 2 for T cell activation
sometimes not needed if pathogen is intact enough to stimulate inflammation on its own
Viral Vaccines
“killed” or inactivated viral vaccines
virus inactivated by heat/chemicals (formaldehyde)
many antigens denatured
adjuvant required to stimulate inflammation
easy, add head and/or chemical treatment
“live” or attenuated viral vaccines
virus not able to replicate in our cells (genetically modified), but antigens are intact
very strong immune response stimulated
no adjuvant needed
requires time and precautions
subunit vaccines
only antigenic part of virus used in vaccine
avoids the need to cultivate massive amounts of deadly virus
adjuvant needed
requires a lot of background research and time to develop
Polio vaccine tragedy
mRNA (Pfizer and Moderna)
mRNA sequence for part of spike protein
our cell produces spike protein
our immune cells respond
PEG in both, can cause severe allergic reactions
protein subunit vaccine (Novavax)
spike protein plus adjuvant
fraction A and fraction C of quillajusaponaria molina extract
viral vector vaccine (J and J)
adenoviral vector carrying DNA instructions for part of spike protein
we’re already exposed to adenovirus and will attack and eliminate
contains large dose of viral vector, blood clot risk
Covid problem: memory doesn’t last long, we don’t know why
Bacterial Vaccines
killed
common strategy for bacteria
heat/chemicals
live (attenuated)
small number of them
BCG used for TB in Europe
salmonella typhi vaccine
20-50% causes side effects
subunit
bacterial toxins are common antigen targets of neutralizing Ab’s (ex. DTP)
capsular polysaccharides (pneumococcus, menigococcos, HiB, etc.)
conjugate vaccines enable high-affinity Ab’s to be made against carb antigens
use carrier protein attached to small carb antigen